Loading…

ViewRay announced plans to collaborate with Medtronic and Elekta on clinical studies of its MRIdian MR-guided radiation therapy system. Elekta committed to investing up to $36 million for a 9.9% stake, and Medtronic will take an undisclosed stake.
“Radiation therapy player ViewRay plans to collaborate with Medtronic and Swedish medtech Elekta, the company said Monday.”medtechdive.com
Summarized from public sources; check the original articles before acting on it.